Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced its participation at four upcoming investor and scientific conferences:
American Society of Hematology (ASH) Annual Meeting
Date: 9 - 12 December 2017
Location: Atlanta, USA
Guggenheim's 5th Annual Boston Healthcare Conference
Date: 13 December 2017
Location: Boston, USA
JP Morgan Healthcare Conference
Trout Access
Date: 8 - 11 January 2018
Location: San Francisco, USA
ODDO BHF Forum 2018
Date: 11 - 12 January 2018
Location: Lyon, France
This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.
American Society of Hematology (ASH) Annual Meeting
Date: 9 - 12 December 2017
Location: Atlanta, USA
Guggenheim's 5th Annual Boston Healthcare Conference
Date: 13 December 2017
Location: Boston, USA
JP Morgan Healthcare Conference
Trout Access
Date: 8 - 11 January 2018
Location: San Francisco, USA
ODDO BHF Forum 2018
Date: 11 - 12 January 2018
Location: Lyon, France
This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.
